Dalfampridine Tablet, Extended Release
Product Images NDC 62756-429

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 62756-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-dalfampridine-figure1 (Spl Dalfampridine Figure1)

The text describes a chart showing the average percent increase in walking speed from baseline for patients who either took a placebo or Dalfampridine 10 mg bid. The chart also includes the percentage of patients in each group.*

FDA Label Image

Spl-dalfampridine-figure2 (Spl Dalfampridine Figure2)

This is a table showing the percentage of patients and their average percent increase in walking speed from baseline. The table has two columns with the percentages ranging from 0% to 100% and the rows showing the placebo control group labeled BPiacebo (N=118) and the treatment group labeled B Daftanpridine 10 mg bid (N=119). The data also shows the average percent increase in walking speed for the treatment group, with the numbers ranging from 210% to >50%.*

FDA Label Image

Spl-dalfampridine-formula (Spl Dalfampridine Formula)

The first text is a formula to calculate an individual's ideal weight based on age and weight in kilograms. The second text is likely a formula to calculate Creatinine Clearance (Crol) based on Serum Creatinine level in milligrams per day, multiplied by 72.*

FDA Label Image

Spl-dalfampridine-label (Spl Dalfampridine Label)

This is a medication package of Dalfampridine Extended-Release Tablets with the National Drug Code (NDC) 62756-429-86. The pharmacist is instructed to provide a medication guide to each patient. The package contains 60 tablets and is available by prescription only. However, the rest of the text seems to be illegible due to errors.*

FDA Label Image

Spl-dalfampridine-structure (Spl Dalfampridine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.